
The global Recombinant Protein Expression System market size is predicted to grow from US$ 3264 million in 2025 to US$ 5737 million in 2031; it is expected to grow at a CAGR of 9.9% from 2025 to 2031.
Proteins produced from such DNA templates are called recombinant proteins. Traditional strategies for recombinant protein expression involvetransfecting cells with a DNA vector that contains the template and then culturing the cells so that they transcribe and translate the desired protein.
The demand for recombinant proteins as therapeutics, such as monoclonal antibodies, vaccines, and growth factors, was driving the growth of the market. Advances in biopharmaceutical research and development contributed to the increasing use of recombinant protein expression systems.
The “Recombinant Protein Expression System Industry Forecast” looks at past sales and reviews total world Recombinant Protein Expression System sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Protein Expression System sales for 2025 through 2031. With Recombinant Protein Expression System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Protein Expression System industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Protein Expression System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Protein Expression System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Protein Expression System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Protein Expression System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Protein Expression System.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Expression System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Mammalian Cell Expression System
Prokaryotic Expression System
Insect Cell Expression System
Yeast Expression System
Cell-free Expression System
Algal-based Expression System
Segmentation by Application:
Pharmaceutical Companies
Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Merck
GenScript
Agilent
Takara Bio
Bio-Rad Laboratories
Qiagen N.V
Charles River
Sartorius
Corning
FUJIFILM Irvine Scientific
Lonza Group
Bioneer Corporation
Promega
Oxford Expression Technologies
ProteoGenix
Abeomics
New England Biolabs
Promab Biotechnologies
Sino Biological
Jena Bioscience
Lifesensors
Leading biology
Peak Proteins
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Protein Expression System Market Size (2020-2031)
2.1.2 Recombinant Protein Expression System Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Recombinant Protein Expression System by Country/Region (2020, 2024 & 2031)
2.2 Recombinant Protein Expression System Segment by Type
2.2.1 Mammalian Cell Expression System
2.2.2 Prokaryotic Expression System
2.2.3 Insect Cell Expression System
2.2.4 Yeast Expression System
2.2.5 Cell-free Expression System
2.2.6 Algal-based Expression System
2.3 Recombinant Protein Expression System Market Size by Type
2.3.1 Recombinant Protein Expression System Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Recombinant Protein Expression System Market Size Market Share by Type (2020-2025)
2.4 Recombinant Protein Expression System Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Research Institutes
2.4.3 Others
2.5 Recombinant Protein Expression System Market Size by Application
2.5.1 Recombinant Protein Expression System Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Recombinant Protein Expression System Market Size Market Share by Application (2020-2025)
3 Recombinant Protein Expression System Market Size by Player
3.1 Recombinant Protein Expression System Market Size Market Share by Player
3.1.1 Global Recombinant Protein Expression System Revenue by Player (2020-2025)
3.1.2 Global Recombinant Protein Expression System Revenue Market Share by Player (2020-2025)
3.2 Global Recombinant Protein Expression System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Recombinant Protein Expression System by Region
4.1 Recombinant Protein Expression System Market Size by Region (2020-2025)
4.2 Global Recombinant Protein Expression System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Protein Expression System Market Size Growth (2020-2025)
4.4 APAC Recombinant Protein Expression System Market Size Growth (2020-2025)
4.5 Europe Recombinant Protein Expression System Market Size Growth (2020-2025)
4.6 Middle East & Africa Recombinant Protein Expression System Market Size Growth (2020-2025)
5 Americas
5.1 Americas Recombinant Protein Expression System Market Size by Country (2020-2025)
5.2 Americas Recombinant Protein Expression System Market Size by Type (2020-2025)
5.3 Americas Recombinant Protein Expression System Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Protein Expression System Market Size by Region (2020-2025)
6.2 APAC Recombinant Protein Expression System Market Size by Type (2020-2025)
6.3 APAC Recombinant Protein Expression System Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Recombinant Protein Expression System Market Size by Country (2020-2025)
7.2 Europe Recombinant Protein Expression System Market Size by Type (2020-2025)
7.3 Europe Recombinant Protein Expression System Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Protein Expression System by Region (2020-2025)
8.2 Middle East & Africa Recombinant Protein Expression System Market Size by Type (2020-2025)
8.3 Middle East & Africa Recombinant Protein Expression System Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Recombinant Protein Expression System Market Forecast
10.1 Global Recombinant Protein Expression System Forecast by Region (2026-2031)
10.1.1 Global Recombinant Protein Expression System Forecast by Region (2026-2031)
10.1.2 Americas Recombinant Protein Expression System Forecast
10.1.3 APAC Recombinant Protein Expression System Forecast
10.1.4 Europe Recombinant Protein Expression System Forecast
10.1.5 Middle East & Africa Recombinant Protein Expression System Forecast
10.2 Americas Recombinant Protein Expression System Forecast by Country (2026-2031)
10.2.1 United States Market Recombinant Protein Expression System Forecast
10.2.2 Canada Market Recombinant Protein Expression System Forecast
10.2.3 Mexico Market Recombinant Protein Expression System Forecast
10.2.4 Brazil Market Recombinant Protein Expression System Forecast
10.3 APAC Recombinant Protein Expression System Forecast by Region (2026-2031)
10.3.1 China Recombinant Protein Expression System Market Forecast
10.3.2 Japan Market Recombinant Protein Expression System Forecast
10.3.3 Korea Market Recombinant Protein Expression System Forecast
10.3.4 Southeast Asia Market Recombinant Protein Expression System Forecast
10.3.5 India Market Recombinant Protein Expression System Forecast
10.3.6 Australia Market Recombinant Protein Expression System Forecast
10.4 Europe Recombinant Protein Expression System Forecast by Country (2026-2031)
10.4.1 Germany Market Recombinant Protein Expression System Forecast
10.4.2 France Market Recombinant Protein Expression System Forecast
10.4.3 UK Market Recombinant Protein Expression System Forecast
10.4.4 Italy Market Recombinant Protein Expression System Forecast
10.4.5 Russia Market Recombinant Protein Expression System Forecast
10.5 Middle East & Africa Recombinant Protein Expression System Forecast by Region (2026-2031)
10.5.1 Egypt Market Recombinant Protein Expression System Forecast
10.5.2 South Africa Market Recombinant Protein Expression System Forecast
10.5.3 Israel Market Recombinant Protein Expression System Forecast
10.5.4 Turkey Market Recombinant Protein Expression System Forecast
10.6 Global Recombinant Protein Expression System Forecast by Type (2026-2031)
10.7 Global Recombinant Protein Expression System Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Recombinant Protein Expression System Forecast
11 Key Players Analysis
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Information
11.1.2 Thermo Fisher Recombinant Protein Expression System Product Offered
11.1.3 Thermo Fisher Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Main Business Overview
11.1.5 Thermo Fisher Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Recombinant Protein Expression System Product Offered
11.2.3 Merck Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 GenScript
11.3.1 GenScript Company Information
11.3.2 GenScript Recombinant Protein Expression System Product Offered
11.3.3 GenScript Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GenScript Main Business Overview
11.3.5 GenScript Latest Developments
11.4 Agilent
11.4.1 Agilent Company Information
11.4.2 Agilent Recombinant Protein Expression System Product Offered
11.4.3 Agilent Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Agilent Main Business Overview
11.4.5 Agilent Latest Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Information
11.5.2 Takara Bio Recombinant Protein Expression System Product Offered
11.5.3 Takara Bio Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Takara Bio Main Business Overview
11.5.5 Takara Bio Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Recombinant Protein Expression System Product Offered
11.6.3 Bio-Rad Laboratories Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
11.7 Qiagen N.V
11.7.1 Qiagen N.V Company Information
11.7.2 Qiagen N.V Recombinant Protein Expression System Product Offered
11.7.3 Qiagen N.V Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Qiagen N.V Main Business Overview
11.7.5 Qiagen N.V Latest Developments
11.8 Charles River
11.8.1 Charles River Company Information
11.8.2 Charles River Recombinant Protein Expression System Product Offered
11.8.3 Charles River Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Charles River Main Business Overview
11.8.5 Charles River Latest Developments
11.9 Sartorius
11.9.1 Sartorius Company Information
11.9.2 Sartorius Recombinant Protein Expression System Product Offered
11.9.3 Sartorius Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Sartorius Main Business Overview
11.9.5 Sartorius Latest Developments
11.10 Corning
11.10.1 Corning Company Information
11.10.2 Corning Recombinant Protein Expression System Product Offered
11.10.3 Corning Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Corning Main Business Overview
11.10.5 Corning Latest Developments
11.11 FUJIFILM Irvine Scientific
11.11.1 FUJIFILM Irvine Scientific Company Information
11.11.2 FUJIFILM Irvine Scientific Recombinant Protein Expression System Product Offered
11.11.3 FUJIFILM Irvine Scientific Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 FUJIFILM Irvine Scientific Main Business Overview
11.11.5 FUJIFILM Irvine Scientific Latest Developments
11.12 Lonza Group
11.12.1 Lonza Group Company Information
11.12.2 Lonza Group Recombinant Protein Expression System Product Offered
11.12.3 Lonza Group Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lonza Group Main Business Overview
11.12.5 Lonza Group Latest Developments
11.13 Bioneer Corporation
11.13.1 Bioneer Corporation Company Information
11.13.2 Bioneer Corporation Recombinant Protein Expression System Product Offered
11.13.3 Bioneer Corporation Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Bioneer Corporation Main Business Overview
11.13.5 Bioneer Corporation Latest Developments
11.14 Promega
11.14.1 Promega Company Information
11.14.2 Promega Recombinant Protein Expression System Product Offered
11.14.3 Promega Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Promega Main Business Overview
11.14.5 Promega Latest Developments
11.15 Oxford Expression Technologies
11.15.1 Oxford Expression Technologies Company Information
11.15.2 Oxford Expression Technologies Recombinant Protein Expression System Product Offered
11.15.3 Oxford Expression Technologies Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Oxford Expression Technologies Main Business Overview
11.15.5 Oxford Expression Technologies Latest Developments
11.16 ProteoGenix
11.16.1 ProteoGenix Company Information
11.16.2 ProteoGenix Recombinant Protein Expression System Product Offered
11.16.3 ProteoGenix Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 ProteoGenix Main Business Overview
11.16.5 ProteoGenix Latest Developments
11.17 Abeomics
11.17.1 Abeomics Company Information
11.17.2 Abeomics Recombinant Protein Expression System Product Offered
11.17.3 Abeomics Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Abeomics Main Business Overview
11.17.5 Abeomics Latest Developments
11.18 New England Biolabs
11.18.1 New England Biolabs Company Information
11.18.2 New England Biolabs Recombinant Protein Expression System Product Offered
11.18.3 New England Biolabs Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 New England Biolabs Main Business Overview
11.18.5 New England Biolabs Latest Developments
11.19 Promab Biotechnologies
11.19.1 Promab Biotechnologies Company Information
11.19.2 Promab Biotechnologies Recombinant Protein Expression System Product Offered
11.19.3 Promab Biotechnologies Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Promab Biotechnologies Main Business Overview
11.19.5 Promab Biotechnologies Latest Developments
11.20 Sino Biological
11.20.1 Sino Biological Company Information
11.20.2 Sino Biological Recombinant Protein Expression System Product Offered
11.20.3 Sino Biological Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Sino Biological Main Business Overview
11.20.5 Sino Biological Latest Developments
11.21 Jena Bioscience
11.21.1 Jena Bioscience Company Information
11.21.2 Jena Bioscience Recombinant Protein Expression System Product Offered
11.21.3 Jena Bioscience Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Jena Bioscience Main Business Overview
11.21.5 Jena Bioscience Latest Developments
11.22 Lifesensors
11.22.1 Lifesensors Company Information
11.22.2 Lifesensors Recombinant Protein Expression System Product Offered
11.22.3 Lifesensors Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Lifesensors Main Business Overview
11.22.5 Lifesensors Latest Developments
11.23 Leading biology
11.23.1 Leading biology Company Information
11.23.2 Leading biology Recombinant Protein Expression System Product Offered
11.23.3 Leading biology Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Leading biology Main Business Overview
11.23.5 Leading biology Latest Developments
11.24 Peak Proteins
11.24.1 Peak Proteins Company Information
11.24.2 Peak Proteins Recombinant Protein Expression System Product Offered
11.24.3 Peak Proteins Recombinant Protein Expression System Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Peak Proteins Main Business Overview
11.24.5 Peak Proteins Latest Developments
12 Research Findings and Conclusion
*If Applicable.
